The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 01, 2022
Filed:
Dec. 23, 2015
Applicant:
Lg Chem, Ltd., Seoul, KR;
Inventors:
Young Kwan Kim, Daejeon, KR;
Sang Yun Park, Daejeon, KR;
Hyun Woo Joo, Daejeon, KR;
Eun Sil Choi, Daejeon, KR;
Seung Yup Paek, Daejeon, KR;
Seung Wan Kang, Daejeon, KR;
Byung Gyu Kim, Daejeon, KR;
Chang Seok Lee, Daejeon, KR;
Sung Wook Kim, Daejeon, KR;
Sang Dae Lee, Daejeon, KR;
Assignee:
LG CHEM. LTD., Seoul, KR;
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/34 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 401/04 (2006.01); A61K 31/4725 (2006.01); C07C 59/31 (2006.01); C07C 229/42 (2006.01); C07C 229/44 (2006.01); C07C 317/22 (2006.01); C07D 207/06 (2006.01); C07D 209/08 (2006.01); C07D 211/34 (2006.01); C07D 213/30 (2006.01); C07D 213/64 (2006.01); C07D 213/70 (2006.01); C07D 231/56 (2006.01); C07D 235/16 (2006.01); C07D 241/18 (2006.01); C07D 261/08 (2006.01); C07D 277/34 (2006.01); C07D 307/42 (2006.01); C07D 307/80 (2006.01); C07D 311/58 (2006.01); C07D 317/46 (2006.01); C07D 317/72 (2006.01); C07D 333/16 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 407/04 (2006.01); C07D 409/04 (2006.01); C07D 409/10 (2006.01); C07D 409/14 (2006.01); C07D 413/10 (2006.01); C07D 413/12 (2006.01); C07D 417/10 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/4725 (2013.01); C07C 59/31 (2013.01); C07C 229/42 (2013.01); C07C 229/44 (2013.01); C07C 317/22 (2013.01); C07D 207/06 (2013.01); C07D 209/08 (2013.01); C07D 211/34 (2013.01); C07D 213/30 (2013.01); C07D 213/64 (2013.01); C07D 213/70 (2013.01); C07D 231/56 (2013.01); C07D 235/16 (2013.01); C07D 239/34 (2013.01); C07D 241/18 (2013.01); C07D 261/08 (2013.01); C07D 277/34 (2013.01); C07D 307/42 (2013.01); C07D 307/80 (2013.01); C07D 311/58 (2013.01); C07D 317/46 (2013.01); C07D 317/72 (2013.01); C07D 333/16 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/04 (2013.01); C07D 409/04 (2013.01); C07D 409/10 (2013.01); C07D 409/14 (2013.01); C07D 413/10 (2013.01); C07D 413/12 (2013.01); C07D 417/10 (2013.01); C07C 2601/04 (2017.05); C07C 2601/08 (2017.05);
Abstract
Compounds having the chemical formula 1, a method for producing the compounds of chemical formula 1, a pharmaceutical composition comprising same, and use thereof as a GPR120 agonist for prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.